Chiron to use Serenex’s Proteome Mining™ Technology

By Business Review Editor

Pharma Deals Review: Vol 2002 Issue 29 (Table of Contents)

Published: 2 Oct-2002

DOI: 10.3833/pdr.v2002.i29.989     ISSN: 1756-7874

Section: Research & Development

Fulltext:

Abstract

Serenex signed a major deal with Chiron to utilize Serenex’s Proteome Mining™ technology to develop novel bioactive therapeutic candidates...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details